Adma Biologics, Inc. Liquidation Value
ADMA
Other
Cash & Equivalents
$87.63M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $87.63M
Total Obligations: -$146.61M
$-58.98M
Per share: $-0.25
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $87.63M
AR: $158.43M
Total Obligations: -$146.61M
$99.45M
Per share: $0.42
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $87.63M
AR: $158.43M
Inventory: $206.47M
Total Obligations: -$146.61M
$305.91M
Per share: $1.29
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $-58.98M | $-0.25 |
| Liquid Liquidation Value | $99.45M | $0.42 |
| Operating Liquidation Value | $305.91M | $1.29 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $87.63M |
| Accounts Receivable | $158.43M |
| Inventory | $206.47M |
| Current Liabilities | $69.54M |
| Long-term Debt | $69.33M |
| Op. Lease Liability | $7.74M |
| Finance Lease | N/A |
| Shares Outstanding | 237.9M |
Explore all 173 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $87.63M | $158.43M | $206.47M | $22.52M | $69.54M | $69.33M | $7.74M | N/A |
| 2025-09-30 | $61.38M | $137.67M | $196.67M | $24.02M | $56.49M | $70.08M | $10.70M | N/A |
| 2025-06-30 | $90.28M | $109.73M | $191.46M | $29.77M | $74.94M | N/A | $10.43M | N/A |
▼ Community Notes